EMA
- Application: EMEA/H/C/004164
- Local brand name: Alecensa
- Status: approved
ALECTINIB (ALECTINIB) regulatory status in European Union.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA has authorised it.
Marketing authorisation holder not available in our data.